{Reference Type}: Journal Article
{Title}: Nanopore sequencing for smear-negative pulmonary tuberculosis-a multicentre prospective study in China.
{Author}: Yan X;Yang G;Wang Y;Wang Y;Cheng J;Xu P;Qiu X;Su L;Liu L;Geng R;You Y;Liu H;Chu N;Ma L;Nie W;
{Journal}: Ann Clin Microbiol Antimicrob
{Volume}: 23
{Issue}: 1
{Year}: 2024 Jun 14
{Factor}: 6.781
{DOI}: 10.1186/s12941-024-00714-2
{Abstract}: <B>OBJECTIVE: </B>In this prospective study, the diagnosis accuracy of nanopore sequencing-based Mycobacterium tuberculosis (MTB) detection was determined through examining bronchoalveolar lavage fluid (BALF) samples from pulmonary tuberculosis (PTB) -suspected patients. Compared the diagnostic performance of nanopore sequencing, mycobacterial growth indicator tube (MGIT) culture and Xpert MTB/rifampin resistance (MTB/RIF) assays.<BR><B>METHODS: </B>Specimens collected from suspected PTB cases across China from September 2021 to April 2022 were tested then assay diagnostic accuracy rates were compared.<BR><B>RESULTS: </B>Among the 111 suspected PTB cases that were ultimately diagnosed as PTB, the diagnostic rate of nanopore sequencing was statistically significant different from other assays (P < 0.05). Fleiss' kappa values of 0.219 and 0.303 indicated fair consistency levels between MTB detection results obtained using nanopore sequencing versus other assays, respectively. Respective PTB diagnostic sensitivity rates of MGIT culture, Xpert MTB/RIF and nanopore sequencing of 36.11%, 40.28% and 83.33% indicated superior sensitivity of nanopore sequencing. Analysis of area under the curve (AUC), Youden's index and accuracy values and the negative predictive value (NPV) indicated superior MTB detection performance for nanopore sequencing (with Xpert MTB/RIF ranking second), while the PTB diagnostic accuracy rate of nanopore sequencing exceeded corresponding rates of the other methods.<BR><B>CONCLUSIONS: </B>In comparison with MGIT culture and Xpert MTB/RIF assays, BALF's nanopore sequencing provided superior MTB detection sensitivity and thus is suitable for testing of sputum-scarce suspected PTB cases. However, negative results obtained using these assays should be confirmed based on additional evidence before ruling out a PTB diagnosis.